Cyberonics to Present at UBS Global Life Sciences Conference

HOUSTON, Sept. 10  /PRNewswire-FirstCall/ -- Cyberonics, Inc. (NASDAQ: CYBX) today announced that Dan Moore, President and Chief Executive Officer, and Greg Browne, Chief Financial Officer, will present at the UBS Global Life Sciences Conference in New York on Tuesday, September 22, 2009 at 4:00 PM EDT. UBS will host a webcast of the presentation live and by replay at http://cc.talkpoint.com/ubsx001/092109a_ke/?entity=82_IT8KY1C.  The replay will be available for 90 days following the conference.  Presentation slides will be available on-line at http://www.cyberonics.com/ by 8:00 AM EDT on Tuesday, September 22, 2009.  The presentation can also be accessed at http://www.cyberonics.com/ by clicking on the link for this webcast.  Access to the webcast is not password protected.

About Cyberonics, Inc. and VNS Therapy(TM)

Cyberonics, Inc. (NASDAQ:CYBX) is a medical technology company with core expertise in neuromodulation.  The company developed and markets the Vagus Nerve Stimulation (VNS) Therapy(TM) System, which is FDA-approved for the treatments of refractory epilepsy and treatment-resistant depression.  The VNS Therapy System uses a surgically implanted medical device that delivers pulsed electrical signals to the vagus nerve.  Cyberonics markets the VNS Therapy System in selected markets worldwide.

Additional information on Cyberonics, Inc. and VNS Therapy(TM) is available at http://www.cyberonics.com/ and http://www.vnstherapy.com/.

  CONTACT INFORMATION:

  Greg Browne, CFO
  Cyberonics, Inc.
  100 Cyberonics Blvd.
  Houston, TX 77058
  Main:  [phone]
  Fax:  [phone]
  

DATASOURCE: Cyberonics, Inc.



CONTACT:  Greg Browne, CFO of Cyberonics, Inc., [phone], fax,

[phone], 



Web Site:  http://www.cyberonics.com/

http://www.vnstherapy.com/ 

Copyright